山東賽托生物(wu)科技(ji)股份有限公司創建于(yu)2010年(nian)(nian),以甾體藥物(wu)中間體研發和(he)生產為主營業務,2017年(nian)(nian)在深交所成功(gong)上市(shi),占地940余畝。
公司立足(zu)于生(sheng)(sheng)物(wu)(wu)制(zhi)藥(yao)(yao)的(de)前沿領(ling)域,歷經多年(nian)的(de)自主研發和技(ji)術(shu)(shu)引進,先一步實現(xian)了生(sheng)(sheng)物(wu)(wu)制(zhi)藥(yao)(yao)技(ji)術(shu)(shu)在甾體(ti)藥(yao)(yao)物(wu)(wu)領(ling)域的(de)規模化(hua)應用,是一家應用基因工程技(ji)術(shu)(shu)及微生(sheng)(sheng)物(wu)(wu)轉化(hua)技(ji)術(shu)(shu),專業(ye)從事(shi)新型(xing)甾體(ti)類原料藥(yao)(yao)物(wu)(wu)研發、生(sheng)(sheng)產為一體(ti)的(de)生(sheng)(sheng)物(wu)(wu)醫藥(yao)(yao)高新技(ji)術(shu)(shu)企業(ye)。
公司堅持(chi)科(ke)技創新路線(xian),與國內(nei)多家(jia)(jia)知名科(ke)研(yan)(yan)(yan)(yan)(yan)院校(xiao)保持(chi)長時間而良(liang)好的合作關系(xi);建有工程(cheng)實驗室一座;從基礎(chu)研(yan)(yan)(yan)(yan)(yan)究到(dao)應用研(yan)(yan)(yan)(yan)(yan)究,通過自(zi)主研(yan)(yan)(yan)(yan)(yan)發、科(ke)研(yan)(yan)(yan)(yan)(yan)機構(gou)合作、聘請國內(nei)外行業專家(jia)(jia)等(deng)多種方(fang)式(shi),建立了國內(nei)一條全系(xi)列甾體產(chan)品生(sheng)產(chan)線(xian);累計(ji)申請各項(xiang)(xiang)知識產(chan)權30項(xiang)(xiang),其中已(yi)授(shou)權19項(xiang)(xiang),年均(jun)研(yan)(yan)(yan)(yan)(yan)發項(xiang)(xiang)目保持(chi)5個以(yi)上。
公(gong)司堅持(chi)用國際化標準(zhun)管(guan)(guan)(guan)理(li)(li)體系來推進公(gong)司的各項管(guan)(guan)(guan)理(li)(li)工(gong)作(zuo),先后通過(guo)ISO90001質量管(guan)(guan)(guan)理(li)(li)體系、ISO14000環境管(guan)(guan)(guan)理(li)(li)體系、ISO18000安全衛生管(guan)(guan)(guan)理(li)(li)體系、ISO50001能(neng)源管(guan)(guan)(guan)理(li)(li)體系等認證。